🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Philip J. Jeng

Cornell University

ORCID: 0000-0002-8336-5536

Also affiliated with Presbyterian Hospital

MedicineSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile
0.210Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Comparison of a national commercial pharmacy naloxone data source to state and city pharmacy naloxone data sources—Rhode Island, Massachusetts, and New York City, 2013–2019

Health Services Research(2023)10.1111/1475-6773.14200
Top 63%
0.210DataRank
Top 63%3 citations

Shapei Yan, Audrey M. Lambert, Jake R. Morgan, Traci C. Green, Philip J. Jeng +7 more

Papers

Driven by 6 papers — median percentile 37. Top paper: “Comparison of a national commercial pharmacy naloxone data source to state and city pharmacy naloxone data sources—Rhode Island, Massachusetts, and New York City, 2013–2019”.

Comparison of a national commercial pharmacy naloxone data source to state and city pharmacy naloxone data sources—Rhode Island, Massachusetts, and New York City, 2013–2019

Health Services Research(2023)10.1111/1475-6773.14200
Top 63%
0.210DataRank
Top 63%3 citations

Shapei Yan, Audrey M. Lambert, Jake R. Morgan, Traci C. Green, Philip J. Jeng +7 more

Health and economic outcomes of treatment with extended-release naltrexone among pre-release prisoners with opioid use disorder (HOPPER): protocol for an evaluation of two randomized effectiveness trials

Addiction Science & Clinical Practice(2020)10.1186/s13722-020-00188-5
N/A
0DataRank · unranked
17 citations

Philip J. Jeng, Sabrina Poole, Ali Jalali, Frank J. Vocci, Michael Gordon +3 more

Determinants of health-related quality of life among individuals with opioid use disorder, recently released from incarceration

Addiction Science & Clinical Practice(2023)10.1186/s13722-023-00375-0
N/A
0DataRank · unranked
0 citations

Ali Jalali, Philip J. Jeng, Sabrina Poole, George Woody, Sean M. Murphy +1 more

Impact of jail-based methadone or buprenorphine treatment on non-fatal opioid overdose after incarceration

Drug and Alcohol Dependence(2024)10.1016/j.drugalcdep.2024.111274
N/A
0DataRank · unranked
12 citations

Sungwoo Lim, Monica Katyal, Keith Goldfeld, Ryan McDonald, Ellen W. Wiewel +10 more

Transitions of care between jail-based medications for opioid use disorder and ongoing treatment in the community: A retrospective cohort study

Drug and Alcohol Dependence(2024)10.1016/j.drugalcdep.2024.111377
N/A
0DataRank · unranked
10 citations

Sungwoo Lim, Teena Cherian, Keith Goldfeld, Monica Katyal, Bianca Rivera +14 more

The association between naloxone claims and proportion of independent versus chain pharmacies: A longitudinal analysis of naloxone claims in the United States

Journal of the American Pharmacists Association(2024)10.1016/j.japh.2024.102093
N/A
0DataRank · unranked
3 citations

Ali Jalali, Sean M. Murphy, Alexander Y. Walley, Benjamin P. Linas, Philip J. Jeng +6 more